RAIsonance, Inc., a group of AI-powered technology solutions companies that is revolutionizing the COVID-19 testing space and helping to meet today’s critical global health challenges, is proud to announce the appointment of Rudy Karsan as its new Chairman of the Board.
“As a company, we are truly thrilled to announce this appointment,” said Kitty Kolding, Founder and CEO of RAIsonance. “It’s especially gratifying for me personally as well, given the powerful advantages Rudy has already brought us as our lead Series A investor and Board Member.”
Mr. Karsan has a long track record as a highly successful entrepreneur and investor who thrives on building companies from the ground up, whether directly or by actively supporting the entrepreneurs he backs. Mr. Karsan led RAIsonance’s Series A investment in March of 2022 to support the company’s anticipated Emergency Use Authorization filing for its groundbreaking new Software as a Medical Device (SaMD) called AudibleHealth Dx. This new software is designed to diagnose COVID-19 in about 2 minutes by conducting an artificial intelligence-powered analysis of the sound of a user’s cough via a mobile application.
“After working closely with him for nearly a year, I realized Rudy would bring a powerful, additional set of capabilities, relationships, and experience to our team in the role of Chairman,” said Kolding. “I’m so pleased that he’s accepted this role. We have significant global health ambitions for this company, and as my partner, Rudy will help us do exactly what we set out to do: change the face of diagnostic testing and meaningfully impact global health.”
Before joining RAIsonance, Mr. Karsan founded and led Kenexa, a leading global provider of business solutions for human resources. The firm completed an IPO in 2005 and was acquired by IBM in December 2012 for $1.3 billion to provide a platform for its Smarter Workforce initiative.
Since 2014, Mr. Karsan has served as managing director of Karlani Capital, a fund devoted to one main objective: enabling the growth and success of ideas that are original, interesting, and useful to people. Karlani Capital wields the expertise and experience of developing companies from one employee to a 1,000 staff and of growing companies from a single dollar to more than a $1 billion in valuation. The firm has assisted entrepreneurs taking their company into the public markets. This is yet another reason why RAIsonance is excited to have Mr. Karsan on board as the company sets its sights on building out its global health operations.
“RAIsonance and Kitty captured my imagination from the word ‘cough’” said Karsan. “This novel technology is designed to allow you to carry a COVID-19 test in your pocket wherever you go, cutting costs and bypassing or solving supply chain challenges, with the goal of revolutionizing COVID testing as we’ve come to know it over the last several years. I am very blessed and fortunate that Kitty honored me with this position. I look forward to serving to the best of my ability and will work diligently to help bring forth her vision to meaningfully impact global health.”
About RAIsonance, Inc.
RAIsonance, Inc., a family of AI-powered technology solution companies headquartered in the Denver Tech Center, is focused on meeting today’s critical health and safety challenges. Founded in March of 2020, AudibleHealth AI, Inc. is the Software as a Medical Device (SaMD) division of RAIsonance specializing in AI/ML diagnostic solutions and platforms. Originally funded by an SBIR grant by the National Science Foundation, the team of medical, artificial intelligence, technology, and medical device specialists focus on developing leading-edge AI/ML-based, scalable, cost-effective diagnostic products across a range of acute and chronic health conditions.